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Abstract
Background: Interactions among genetic loci are believed to play an important role in disease risk. While many
methods have been proposed for detecting such interactions, their relative performance remains largely unclear,
mainly because different data sources, detection performance criteria, and experimental protocols were used in the
papers introducing these methods and in subsequent studies. Moreover, there have been very few studies strictly
focused on comparison of existing methods. Given the importance of detecting gene-gene and gene-environment
interactions, a rigorous, comprehensive comparison of performance and limitations of available interaction
detection methods is warranted.
Results: We report a comparison of eight representative methods, of which seven were specifically designed to
detect interactions among single nucleotide polymorphisms (SNPs), with the last a popular main-effect testing
method used as a baseline for performance evaluation. The selected methods, multifactor dimensionality reduction
(MDR), full interaction model (FIM), information gain (IG), Bayesian epistasis association mapping (BEAM), SNP
harvester (SH), maximum entropy conditional probability modeling (MECPM), logistic regression with an interaction
term (LRIT), and logistic regression (LR) were compared on a large number of simulated data sets, each, consistent
with complex disease models, embedding multiple sets of interacting SNPs, under different interaction models. The
assessment criteria included several relevant detection power measures, family-wise type I error rate, and
computational complexity. There are several important results from this study. First, while some SNPs in
interactions with strong effects are successfully detected, most of the methods miss many interacting SNPs at an
acceptable rate of false positives. In this study, the best-performing method was MECPM. Second, the statistical
significance assessment criteria, used by some of the methods to control the type I error rate, are quite
conservative, thereby limiting their power and making it difficult to fairly compare them. Third, as expected, power
varies for different models and as a function of penetrance, minor allele frequency, linkage disequilibrium and
marginal effects. Fourth, the analytical relationships between power and these factors are derived, aiding in the
interpretation of the study results. Fifth, for these methods the magnitude of the main effect influences the power
of the tests. Sixth, most methods can detect some ground-truth SNPs but have modest power to detect the whole
set of interacting SNPs.
Conclusion: This comparison study provides new insights into the strengths and limitations of current methods for
detecting interacting loci. This study, along with freely available simulation tools we provide, should help support
development of improved methods. The simulation tools are available at: http://code.google.com/p/simulation-
tool-bmc-ms9169818735220977/downloads/list.
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Genome-wide association studies (GWAS) have been
widely applied recently to identify SNPs associated with
common human diseases [1-9], including cardiovascular
diseases [6,10-13], diabetes [6,14-18], lupus [19-21],
autoimmune diseases [22], autism [23], and cancer
[24-27]. However, with few exceptions [13,15,17,24], the
discovered genetic variants with significant main effects
account for only a small fraction of clinically important
phenotypic variations for many traits [5,28]. While there
are multiple causes for missing some well-known
genetic risk factors or disease heritability (including e.g.,
rare variants not genotyped in a GWAS study), a fre-
quently cited reason is that most common diseases have
complex mechanisms, involving multi-locus gene-gene
and gene-environment interactions [5,28-31]. For detect-
ing interacting loci in high dimensional GWAS data
with sufficient power and computational feasibility,
some pioneering work, with promising results, has been
reported, encompassing: i) real GWAS study papers, as
cited above; ii) interaction detection methodology
[32-44]; iii) theoretical papers that characterize the prin-
ciple problem (interaction detection) and its challenges
[30,45-47]; iv) review and methods comparison papers
[29,31,47-51].
Novel Methods for Detecting Interacting SNPs
A variety of SNP interaction detection methods have
been recently proposed. In particular, multifactor
dimensionality reduction (MDR) [33] measures the asso-
ciation between SNPs and disease risk using prediction
accuracy of selected multifactor models. Full interaction
model (FIM) [41] applies logistic regression, 3 using
d-1
binary variables constructed based on a d-SNP subset.
Information gain (IG) [34,52] measures mutual informa-
tion to assess multi-locus joint effects. Bayesian epistasis
association mapping (BEAM) [32] treats the disease-
associated markers and their interactions via a Bayesian
partitioning model and computes, via Markov chain
Monte Carlo (MCMC), the posterior probability that
each SNP set is associated with the disease. SNP har-
vester (SH) [39] proposes a heuristic search to reduce
computational complexity and detect SNP interactions
with weak marginal effects. Random forest (RF) [44] is
an ensemble classifier consisting of many decision trees,
each tree using only a subset of the available features
for class decision making. Thus, the detected features
(SNPs) are the ones most frequently used by trees in the
ensemble. Logic regression (LOR) [36] identifies interac-
tions as Boolean (logical) combinations of SNPs. In [42],
an extension of logic regression was also proposed to
identify SNP interactions explanatory for the disease sta-
tus, with two measures devised for quantifying the
importance of these interactions for the accuracy of
disease prediction. Treating SNPs and their interaction
terms as predictors, penalized logistic regression (PLR)
[37] maximizes the model log-likelihood subject to an
L2-norm constraint on the coefficients. Related to FIM
and PLR, adaptive group lasso (AGL) [43] adds all possi-
ble interaction effects at first and second order to a
group lasso model, with L1-norm penalized logistic
regression used to identify a sparse set of marginal and
interaction terms. Maximum entropy conditional prob-
ability modeling (MECPM) [40], applying a novel, deter-
ministic model structure search, builds multiple,
variable-order interactions into a phenotype-posterior
model, and is coupled with the Bayesian Information
Criterion (BIC) to estimate the number of interaction
models present. Logistic regression with an interaction
term (LRIT) has been widely applied to detect interac-
tions [35]. It treats the multiplicative term between
SNPs, along with individual SNP terms, as predictors in
the logistic regression model.
Evaluation of Methods to Detect Interacting SNPs
Despite strong current interest in this area and a num-
ber of recent review articles [29,31,47-51], no commonly
accepted performance standards for evaluating methods
to detect multi-locus interactions have been established.
For example, one might choose to evaluate power to
detect individual SNPs involved in interactions, or
power to precisely detect whole (multi-SNP) interac-
tions. Moreover, the relationship between the power to
detect interacting loci and the factors on which it
depends (penetrance, minor allele frequency (MAF),
main effects, and LD), while considered in some pre-
vious studies [32,41,43,45,53], has not been fully investi-
gated, either experimentally or analytically. Most
importantly, although some assessment and performance
comparison was undertaken both in the original papers
proposing new methods [32-34,39,41,43] and in the
comparison papers [49,50], it is difficult to draw defini-
tive conclusions about the absolute and relative perfor-
mance of these methods from this body of studies due
to the following: (1) each study was based on a different
simulation data set and a different set of experimental
protocols (including the detection power definition
used, the sample size, the number of evaluated SNPs,
and the computational allowance of methods). While
use of different data sets and protocols may be well-war-
ranted, as it may allow a study to focus on unique sce-
narios/application contexts not considered previously, it
also makes it difficult to compare the performance of
methods, excepting those head-to-head evaluated in the
same study. Some methods were found to perform quite
favorably in one study but poorly in others. For exam-
ple, MDR [33] performed well in the original simulation
s t u d ya n dt h ec o m p a r i s o np a p e r[ 5 0 ] ,b u tp o o r l yi n
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Page 2 of 23subsequent studies [32,40,43]; (2) often, only simple
cases were tested, which may not reflect the realistic
application of a method. For example, a common prac-
tice is to include only a single interaction model in the
data [32-34,39,41,50], whereas common diseases are
usually complex, with multiple genetic causes [28], sug-
gesting that multiple interaction models should be pre-
sent. Our previous papers [40,54] considered multiple
interaction models, but an insufficient number of data
set replications to draw definitive conclusions on relative
performance of methods [50]. also evaluated multiple
interaction models, but only compared three methods,
evaluated only one interaction power definition, and did
not comprehensively evaluate the effects of penetrance,
MAF, main effects, and linkage disequilibrium (LD) on
power; (3) only limited interaction patterns were consid-
ered, e.g. 2-way interactions but no higher-order interac-
tions in [43,49]. This is an important limitation,
especially considering that data sets with 1000 or fewer
SNPs were evaluated in these studies - in such cases,
exhaustive evaluation of candidate pairwise interactions
is computationally feasible, whereas heuristic search,
which will affect detection power in practice, is necessi-
tated if either higher order interactions or much larger
SNP sets are considered. Thus, to more realistically
assess detection power, either higher order interactions
and/or more SNPs should be considered; (4) Perhaps
most critically, methods providing P-value assessments
[32,39,41] evaluated power for a given significance
t h r e s h o l d ,b u td i dn o tr i g o r o u s l ye v a l u a t et h eaccuracy
of the P-value assessment, i.e. whether the Bonferroni-
corrected P-value truly reflects the family-wise type I
error rate [55]. This evaluation is of great importance
for methods that use asymptotic statistics [32,39,41],
since it reveals whether or not the asymptotic P-value is
a reliable detection criterion. Specifically, the P-value
could be too liberal (in which case, more family-wise
errors than expected will occur in practice and the esti-
mated detection power is too optimistic) or too conser-
vative (in which case the detection power estimate is
too pessimistic). By not performing such assessment, it
is unclear even whether use of P-values is providing a
fair comparison of detection power between methods (i.
e., for the same family-wise error rate) in [32,39,41]. We
further note that although there were efforts to measure
the type I error rate in [32,43,50], the evaluations were
not based on the commonly used family-wise error rate,
but rather on another definition of type 1 error [32] that
does not directly reflect the Bonferroni-corrected P-
v a l u e ;( 5 )I nm o s tp a s ts t u d i es [32-34,39,41,43,50], only
a single definition of an interaction detection event
(and, thus, a single measure of detection power) was
used. However, this does not capture the full range of
relevant detection events for some applications of
GWAS. In particular, in some works an exact joint
detection event is defined, i.e. detection is successful
only if all SNPs involved in the interaction (and only
these SNPs) are jointly detected [43,50]. This is a strin-
gent definition that gives no credit to a method that
detects a subset of the interacting SNPs (e.g.3o ft h e
SNPs in a 5-way interaction), even though such partial
detection is clearly helpful if e.g. one is seeking to iden-
t i f yag e n ep a t h w a y ,o ri ft h er e m a i n i n gS N P si nt h e
interaction can be subsequently detected by applying
more sensitive (and computationally heavy) methods.
Exact detection is especially stringent when there are
multiple interactions present, with the disease risk effec-
tively divided between the multiple models. Finally, we
note that individual methodsh a v et h e i ro w ni n d u c t i v e
biases and, thus, may perform better under different
detection criteria - one method may find more ground-
truth SNPs, while another may be more successful at
finding whole interactions. Use of multiple power defini-
tions can reveal these differences between methods; (6)
Most of the proposed methods (e.g.M D R ,F I M ,B E A M ,
MECPM, SH) are designed to detect both main effects
and interaction effects, while to date they have only
been evaluated on data sets containing interactions. It is
thus also meaningful to measu r eh o we f f e c t i v et h e ya r e
at detecting SNPs with only main effects, and how many
false positive interactions they detect involving main
effect SNPs.
Finally, we note that there are very few true (strict)
comparison papers - most studies have focused on
developing new methods, with experimental evaluation
not the central paper focus. Two exceptions are [50]
and [49]. However, they both embedded only a single
interaction model in the data and considered data sets
with only 100 SNPs; Moreover, [50] evaluated only 2-
way and 3-way interaction detection, while [49] evalu-
ated only two-way interaction detection.
The aforementioned limitations of previous studies are
not surprising because of the following challenges asso-
ciated with comparison studies: (1) it is impractical to
evaluate methods on all of the (numerous possible)
interaction models; (2) multiple aforementioned factors
(MAF, penetrance, LD) jointly decide interaction effects,
which thus entails extensive study design, experimenta-
tion, and computational efforts; (3) many replicated data
sets are required to accurately estimate power and
family-wise type I error rate, further increasing compu-
tational burden; (4) computational costs of some meth-
ods are inherently high; thus a thorough evaluation of
these methods is a difficult hurdle; and (5) fair evalua-
tion criteria are not easily designed because distinct
methods have different inductive biases and produce dif-
ferent forms of output (e.g., some give P-value assess-
ments while others only provide SNP rankings); (6)
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to identify multiple sets of predictors that are jointly
associated with outcomes of interest.
Addressing the above challenges, a ground-truth based
comparative study is reported in this paper. The goals
are three-fold: (1) to describe and make publicly avail-
able simulation tools for evaluating performance of any
technique designed to detect interactions among genetic
variants in case-control studies; (2) to use these tools to
compare performance of eight popular SNP detection
methods; (3) to develop analytical relationships between
power to detect interacting SNPs and the factors on
which it depends (penetrance, MAF, main effects, LD),
which support and help explain the experimental results.
Our simulation tools allow users to vary the para-
meters that impact performance, including interaction
pattern, MAF, penetrance (which together determine
the strength of the association) and the sporadic disease
rate, while maintaining the normally occurring linkage
disequilibrium structure. Also, the simulation tools
allow users to embed multiple interaction models within
each data set. These tools can be used to produce any
number of test sets composed of user specified numbers
of subjects and SNPs.
Our comparison study, based on these simulation
tools, involves thousands of data sets and consists of
three steps, as graphically illustrated in Figure 1. Step 1
(with no ground-truth SNPs present) measures the
empirical family-wise type I error rate, which has not
been evaluated in many previous studies, and yet is criti-
cally important if the (e.g. P-value based) significance
threshold is used as the criterion for detecting interact-
ing SNPs.
In particular, foreshadowing our Step 1 results, we will
find that most methods (except LR) in this study that
produce P-values in fact produce conservative ones,
with the degree of conservativeness method-dependent.
Thus, using the same P-value threshold for all methods
will not ensure the methods are being fairly compared,
at a common family-wise error rate. Both for this rea-
son, and because some of the methods do not even pro-
duce P-values, in Step 2 we evaluate detection power as
a function of the number of top-ranked SNPs, rather
than for a specified P-value threshold. Accordingly, note
t h el o g i c a ls t r u c t u r ei nF i g u r e1 ,w i t ht h eS t e p1r e s u l t s
helping us to determine how to evaluate detection
power in Step 2.
As aforementioned, Step 2 (with a variety of ground-
truth interaction models present) investigates power.
W ef o r m u l a t eam o r ec h a l l e n g i n g ,y e tm o r er e a l i s t i c
situation than most previous studies by including multi-
ple ground-truth interaction models in each simulated
data set. These simulations are motivated in part by our
experience with complex genetic diseases such as
Comprehensive performance
evaluation of interaction
detection methods
Step 1: assess the
accuracy of P-value based
significance assessment
Step 2: assess
the detection power for
interacting SNPs
Compare power based on
statistical significance
Compare power based on
SNP ranking
Power definition 1:
Interaction
detection power
Power definition 2:
Exact interaction
detection power
Power definition 3:
Partial interaction
detection power
Power definition 4:
Individual SNP
detection power
Step 3: assess
the ability of methods to
detect main-effects
Different
conservativeness level
Compare family-wise error
rate to P value threshold
Compare the number of
false positive interactions
Simulation 1:
no ground-truth SNP
Simulation 2:
interacting SNPs only
Simulation 3:
main-effect SNPs only
Inappropriate
Simulation
Analytical results on the relation between
detection power and the factors (Penetrance, MAF, LD)
Figure 1 A flowchart for the performance evaluation of interaction detection methods.
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Page 4 of 23autoimmune diseases, diabetes and end-stage renal dis-
ease [18,19,56,57]. In total, ninety different interaction
models are investigated in this study, jointly determined
by 5 underlying interaction types and 3 parameters, con-
trolling penetrance, MAF, and LD. Step 3 investigates
the power to detect main effect SNPs, i.e. we investigate
how the methods (many of which are designed to detect
both interactions and main effect SNPs) perform when
only main effects are present in the data.
The main contributions and novelty of our compari-
son study are: (1) comprehensive comparison of state-
of-the-art techniques on realistic simulated data sets,
each of which includes multiple interaction models; (2)
new proposed power criteria, well-matched to distinct
GWAS applications (e.g., detection of “at least one SNP
in an interaction”); (3) evaluation of the accuracy of (P-
value based) significance assessments made by the
detection methods; (4) investigation of detection of
models with variable order interactions (up to 5th
order) in SNP data sets; (5) new analytical results on the
relationship between interaction parameters and statisti-
cal power; (6) investigation of the flexibility of interac-
tion-detection methods, i.e. whether (and with what
accuracy) they can detect both interactions and main
effects; (7) discoveries concerning relative performance
of methods (e.g., comparative evaluation of the promis-
ing recent method, MECPM). Since we are presenting a
diversity of results, both experimental and analytical, to
assist the reader in navigating our work, Figure 1 gives a
graphical summary of our experimental steps, the results
produced there from, and the connections between the
different results, both experimental and analytical.
Results
Experimental Design and Protocol
We selected eight representative methods for evaluation,
based on their reported effectiveness and computational
efficiency. Seven of them (MDR, FIM, IG, BEAM, SH,
MECPM and LRIT) are designed to detect interacting
loci, with the remaining one based on the widely-used
logistic regression model (LR). LR, using only main
effect terms, serves as a baseline method to compare
against all the interaction-detection methods, i.e., to see
whether they give any advantage over pure “main effect”
methods when the goal is simply to detect the subset of
SNPs that either individually, or via interactions, are
predictive of the phenotype. The description of the eight
methods is given in the “Methods” part.
Simulation Data Sets
Each data set contains individuals simulated from the
control subjects genotyped by the 317K-SNP Illumina
HumanHap300 BeadChip as part of the New York City
Cancer Control Project (NYCCCP). To facilitate this
investigation [40], a flexible simulation program was
written that generates user defined sample size, number
of SNPs, no missing data or missing data patterns con-
sistent with the observed missing data in the original
genome scan, and affected or unaffected disease status
under the null hypothesis (i.e., no associations in the
genome) or under the alternative hypothesis (i.e., hard-
coded penetrance functions). Missing data is filled in
completely at random and proportional to the allele fre-
quencies in the original data. The data sets were pro-
duced as follows. Consider a matrix with 223 rows
corresponding to NYCCCP individuals and 317,503 col-
umns corresponding to the 317,503 SNPs. The elements
of this matrix are the individual genotypes. The columns
were partitioned into blocks of 500 SNPs, i.e. 636
blocks, with the last block containing only 3 SNPs. The
simulated genome scan data for each individual was
obtained by random draws (with replacement) from a
real data matrix of 223 individuals and 636 blocks of
500 SNPs. Specifically, the simulated data for an indivi-
dual was generated by randomly selecting the first block
from the 223 individuals (rows), randomly selecting with
replacement the second block from the 223 individuals,
randomly selecting with replacement the third block
from the 223 individuals, and so on. Thus the data
retains the basic patterns of linkage disequilibrium (bro-
ken by strong recombination hotspots), missing data,
and allele frequencies observed in the original genome
scan data. The exception to this is only at the 635
breaks in the genome corresponding to the block
boundaries. Figure 2 visually illustrates this simulation
approach for randomly resampling genome scan data
starting from the real NYCCP scans. The simulations
presented here correspond to approximately 2000 sub-
jects simulated under the alternative hypothesis
described below and no missing data. Only autosomal
loci are considered in the data.
The eight methods were applied to sets of
1000~10,000 SNPs selected at random from the autoso-
mal loci. This number of SNPs is consistent with a
GWAS study following an initial SNP screening stage
and also with pathway-based association studies. When
selecting SNPs, we first removed those with genotypes
that significantly deviate from Hardy-Weinberg equili-
brium, and then selected the desired number of ground-
truth and “null” SNPs. For each replication data set,
ground-truth SNPs were randomly selected, according
to the requirements of MAF (within a narrow window
of tolerance), and “null” SNPs were chosen completely
at random. The simulations reported assume that the
disease risk is explained by several ground-truth interac-
tion models and the sporadic disease rate S,w h i c h
accounts for the missing heritability and other disease-
related factors. Let Pr(di), r = 1,2,...,R be the disease
probability generated by R interaction models for the ith
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Page 5 of 23subject. Assuming all disease factors act independently,
disease risk of this subject is then
P(di)=1−
R 
r=1
(1 − Pr(di))(1 − S). (1)
The simulation data sets have different ground truth
interaction models Pr(di), r = 1,2,...R and the sporadic
disease rate S for different steps. For Step 1, we did not
embed any ground truth SNPs in the data sets; for Step
2, we embedded five interaction models in each data set;
and for Step 3, we embedded five main-effect-only SNPs
in each data set. In all three steps, we adjusted the
sporadic rate S so that each data set has approximately
1,000 cases and 1,000 controls, the typical situation
(balanced cases and controls) in GWAS studies, e.g. in
Step 1, S = 0.5. The ground truth interaction models in
Step 2 and the ground truth main-effect-only SNPs will
be described later.
In Figure 3, we provide a flowchart detailing all of the
s t e p s( a sd e s c r i b e da b o v e )u s e di np r o d u c i n go u rs i m u -
lated GWAS data sets.
The simulation approach used in this comparison
study is the same as that used in [40]. Our simulation
approach has one commonality with, but two main dif-
ferences from the simulation approaches used in the
previous methods and comparison study papers evaluat-
ing MDR, IG, FIM, SH, and BEAM [32-34,39,41,50].
Both in these papers and in our current study, all SNPs
are consistent with Hardy-Weinberg Equilibrium. How-
ever, in these previous papers, the simulated data were
purely synthetic, generated according to user-specified
allele frequencies [29-31,36,38,47]. By contrast, our
simulated data is obtained by resampling from real gen-
ome scan data and is thus more realistic, preserving the
allele frequencies and LD structure manifested by the
original genome scan data. Another resampling simula-
tion method was proposed in [58,59], but this approach
has not been used for evaluating the MDR, IG, FIM,
SH, and BEAM methods. Another important distinction
between our simulation method and other simulation
methods lies in the phenotype generation. In our simu-
lation, multiple interactions simultaneously exist in each
data set (which is reasonable considering complex dis-
ease mechanisms) and jointly decide the phenotype; by
contrast, other simulation methods usually embed only
one SNP interaction (i.e., single interaction model) in
each data set [32-34,39,41,50]. Also, we consider interac-
tions with interaction order from 2 to 5, while most
other simulations [33,34,39,41,50] only consider interac-
tions with interaction order up to 3.
As mentioned previously, our simulation study con-
sists of three main experimental steps, which we next
more fully describe.
Step 1: assess family-wise type I error rate
An accurate family-wise type I error rate is crucial for
methods that select candidate SNPs based on their P-
values and for reliably comparing methods. If the
family-wise type I error rate is either conservative or lib-
eral, the P-value loses its intended meaning and does
not reflect the actual false positive rate. That is, we will
not be able to control how many false positives are
detected by setting a (e.g. P-value based) threshold. For
example, a method with a lower family-wise type I error
Figure 2 A visual illustration of SNP “blocking” and random sampling, used for generating simulated individuals. “Ind i“ denotes the ith
real individual, and “Sim Ind” denotes the simulated individual. First, genomes of the real individuals are segmented into a number of blocks;
second, for each block, a genome segment is randomly drawn from the set of real individuals; finally, the randomly drawn genome segments,
for all blocks, are stitched together to form a simulated individual.
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a threshold that overestimates the empirical false posi-
tive rate; thus, fewer false positives (than the target) will
be selected, likely also leading to fewer true associations
being identified.
BEAM, SH and FIM detect significant SNPs based on
P-values calculated from asymptotic distributions and
heuristic searches. Thus, based on the preceding discus-
sion, evaluating the accuracy of their P-value assess-
ments is not only of theoretical importance (how well
their proposed asymptotic distributions approximate the
real distribution), but also of great practical necessity in
applying these methods.
To evaluate the accuracy of P-value assessment, we
replicated 1,000 data sets by repeatedly randomly select-
ing 1,000 null SNPs from the SNP pool, i.e. to easily
assess family-wise type I error rate, no ground-truth
SNPs were embedded in these data sets.
Step 2: assess power
In step 2, each data set has N SNPs, with 15 ground-
truth SNPs and N-15 null SNPs, selected via the proce-
dure described in the “Simulation Data Sets“ subsection.
N is chosen to be either 1000 or 10,000 for different
experiments. There are several points to make regarding
the number of SNPs we consider. First, assuming
approximately 1000~10,000 SNPs is realistic for candi-
date gene and biological pathway studies where interac-
tion detection is needed. Second, considering GWAS
studies, a 0.15%~1.5% percentage of ground-truth SNPs
realistically models the output of first stage SNP screen-
ing/filtering (which greatly reduces the number of candi-
date SNPs) in the widely-applied 2-stage GWAS
detection process. Finally, the 1000~10,000 SNPs
considered here is much larger than the 100 SNPs in
the previous comparison study [49,50] and comparable
to that considered in several other recent papers.
The 15 ground-truth SNPs each participate in one of
5 ground-truth SNP interactions, which contribute inde-
pendently to the disease, as described by equation (1).
There are three standard factors that determine interac-
tions: penetrance, MAF and LD [3,7]. Penetrance is the
proportion of individuals with a specific genotype who
manifest the phenotype. For example, if all individuals
with a specific disease genotype show the disease pheno-
type, then the penetrance value is 1 and the genotype is
said to be “completely penetrant"; otherwise, it is
“incompletely penetrant” [3]. LD is the non-random
association of alleles of different linked polymorphisms
in a population [7]. MAF is the frequency of the least
common allele of a polymorphic locus. It has a value
that lies between 0 and 0.5, and can vary between popu-
lations [7]. The 5 ground-truth SNP interactions are
jointly determined by 5 basic model types and 3 (dis-
crete-valued) parameters, controlling the MAF, pene-
trance, and LD, which will be specified later. Based on
the choices for these 3 parameters, there are 3 × 3 × 2
= 18 possible parameter configurations (so the afore-
mentioned ninety models are generated by the 5 basic
model types, each with 18 different parameter settings).
Each configuration is applied simultaneously to the 5
basic models, thus yielding 5 fully specified interaction
models for a given data set. With some allowable ran-
domness in the 5 new interaction models, we generated
100 replication data sets for each configuration with N
= 1000, and 10 replication data sets for one typical con-
figuration with N=10,000; thus we have in total 18 ×
Real SNP data
Individuals generated by segmenting
and random sampling
Generating
disease status
Selecting ground-truth
SNPs based on MAF
MAF Penetrance
Basic disease models
Randomly Selecting
null SNPs
Simulated data
x ȕ x ș
Sporadic
rate
Figure 3 A flowchart detailing all of the steps used in producing the simulated GWAS data sets.
Chen et al. BMC Genomics 2011, 12:344
http://www.biomedcentral.com/1471-2164/12/344
Page 7 of 23100+10 = 1,810 data sets in step 2, involving 18 × 5 =
90 interaction models.
The 5 basic models vary in interaction order, genetic
models (dominant, recessive, or additive), incomplete/
complete penetrance, MAF, and marginal effects. To
indicate the strength of interaction effects and main
effects for each basic model, we calculated the odds
ratio by dichotomizing the genotypes of each interaction
into a group with the lowest penetrance value (usually
with “0” penetrance) and another group with higher
penetrance values (the specific calculation can be found
in section S4 of the Additional file 1).
T h e5b a s i cm o d e l sa r ed e f i n e db yt h ep e n e t r a n c e
tables and MAFs below. The penetrance function is the
probability of disease given the individual’sg e n o t y p e .
Thus, the penetrance tables show the probability of
developing disease given the genotypes [3,60], with each
table entry being the disease probability conditional on
the specific single or multi-locus genotypes. The interac-
tion models are motivated by our experience studying
complex genetic traits where there are multiple loci con-
tributing to disease risk. Specifically, the simulation
study is motivated by our experience in autoimmune
diseases, diabetes and renal diseases where there are
some larger effects (e.g., human leukocyte antigen region
in autoimmune diseases such as systemic lupus erythe-
matosus, neonatal lupus, and juvenile arthritis [19]; and
gene APOL1 in end-stage renal disease in African
Americans [18]), and multiple modest to smaller effects
with 1.1 < odds ratios < 1.3. To date, there are few
robustly established (i.e., with convincing discovery evi-
dence on multiple replications in independent cohorts)
gene-gene interactions in the human disease literature.
Thus, we attempted to be consistent with the complex
genetic disease paradigm a n da s s u m e dm u l t i p l el o c i ,
several interacting, contribute to the risk of disease. We
examined combinations of SNPs in the lupus genome-
wide scan (Harley et al, 2008) to estimate some exam-
ples of potential two-locus interactions as well as con-
structed other higher-order interactions consistent with
traditional interpretations of Mendelian inheritance (i.e.,
dominant, additive or recessive genetic model) but span-
ning multiple loci. Some interactions are based on a
two-locus, common allele with a low penetrance model
as might be hypothesized in diabetes from the “thrifty
gene hypothesis” [56] and other multi-locus models are
modest penetrance models for the low frequency alleles.
Additional motivation comes from studies of epistasis
[57]. The five locus interaction is a conjectural one that
should challenge these analytic methods.
Basic model 1-.two-locus interaction under a domi-
nant model for the major allele. The model is for two
very common but low penetrant alleles. The MAFs at
these two loci are both 0.25. This model is expected to
generate 62 cases per 1000 subjects. The odds ratio is
1.16 for the joint interaction effect between A and B,
and 1.15 for main effects of both A and B.T h i sm o d e l
simulates the situation of common disease where the
major allele is disease-related but with weak interaction
effects. “M1” denotes model 1. GA
11 denotes the homozy-
gous major allele genotype of SNP A; GA
12 denotes the
heterozygous genotype of SNP A; GA
22 denotes the
homozygous minor allele genotype of SNP A; likewise
for the notations in the other basic models.
M1 GA
11 GA
12 GA
22
GB
11 0.07 0.07 0
GB
12 0.07 0.07 0
GB
22 000
Basic model 2- two-locus interaction for common
alleles under a dominant genetic model at each locus.
The minor allele frequencies are 0.20 for locus A and
0.30 for locus B. This model is expected to generate 102
cases per 1000 subjects. The odds ratio is 3.79 for the
joint interaction effect between A and B,1 . 8 9f o rt h e
main effect of A and 1.56 for the main effect of B.T h i s
model simulates the situation that the minor allele is
disease-related, and both interaction effects and main
effects are strong.
M2 GA
11 GA
12 GA
22
GB
11 000
GB
12 00 . 5 0 . 7
GB
22 00 . 7 0 . 7
Basic model 3- three-locus interaction, common
alleles, incomplete penetrance. The MAFs at the three
loci are 0.40 for A, 0.25 for B, and 0.25 for C.T h i s
model is expected to generate 46 cases per 1000 sub-
jects. The odds ratio is 2.28 for the joint interaction
effect among A, B and C, 1.16 for the main effect of A,
1.25 for the main effect of B, and 1.25 for the main
effect of C.
M3 GA
11 GA
12 GA
22
GC
11 GC
12 GC
22 GC
11 GC
12 GC
22 GC
11 GC
12 GC
22
GB
11 00000 0 00 0
GB
12 0 0 0 0 0.35 0.35 0 0.35 0.7
GB
22 0 0 0 0 0.35 0.7 0 0.7 0.7
Basic model 4- three-locus interaction among com-
mon alleles. The minor allele frequencies are 0.25 for A,
0.20 for B, and 0.20 for C. This model is expected to
generate 26 cases per 1000 subjects. The odds ratio is
5.79 for the joint interaction effect among A, B and C,
2.45 for the main effect of A, 1.06 for the main effect of
B, and 1.06 for the main effect of C. This model has
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but weak main effects at B and C.T w o - S N Ps u b s e t so f
the three-locus interaction, {A, B}a n d{ A, C}, also have
strong effects.
Basic model 5- five-locus interaction among common
alleles. It assumes a MAF of 0.30 at each locus and has
a penetrance value of 0.63 if the minor allele is present
at each locus; and 0 otherwise. In equation form, the
penetrance function is:
P(D|GA
12or 22 ∩ GB
12or22 ∩ GC
12or22 ∩ GD
12or 22 ∩ GE
12or22) = 0.63; 0 otherwise,
where D means the subject gets disease. This model is
expected to generate 22 cases per 1000 subjects. The
odds ratio is 4.48 for the joint interaction effect among
the five loci, and 1.09 for the main effect at all five loci.
This model simulates the situation of significant high-
order interaction effects but weak main effects.
Three parameters are used to assess the robustness
of the various methods to variations in penetrance,
MAF, and LD, because i) as aforementioned, penetrance,
MAF, and LD jointly define the disease model, and thus
decide the disease status; ii) it is of interests, in the field
of SNP interaction detection, to explore how detection
power varies with these parameters [32,34,41,43,50]; iii)
we have derived the analytical relationships between
interaction effects and these parameters in the Addi-
tional file 1, so a simulation study using these para-
meters provides us the opportunity to validate the
analytical relationships in an empirical way. For each
basic model, we control its penetrance by multiplying
every value in the penetrance table by the penetrance
factor (multiplier) θ Î{1,1.3,1.4} (the larger θ is, the lar-
ger disease risk there will be); we discount the MAF by
multiplying the MAF of each SNP by a MAF factor b Î
{1,0.9,0.7} (the larger b is, the larger frequency the
minor allele will have); and to control the LD level, we
replace each ground-truth SNP by an “LD SNP”,w h i c h
has a certain correlation coefficient l Î{0.8,null}w i t h
the ground-truth SNP (l = null means we do not replace
the ground-truth SNP). The “LD SNP” simulates the
realistic case where the ground-truth SNP is not directly
genotyped; in this case we may detect a SNP in LD with
the ground-truth SNP. For example, for basic model 2,
under parameters θ, b,l , the MAFs are 0.2 * b for locus
A and 0.3 * b for locus B, θ determines a new
penetrance function shown below, and if l =0 . 8 ,w e
replace A/B by a SNP correlated to A/B with correlation
coefficient 0.8.
GA
11 GA
12 GA
22
GB
11 00 0
GB
12 00 . 5 ∗ θ 0.7 ∗ θ
GB
22 00 . 7 ∗ θ 0.7 ∗ θ
The theoretical, analytical relationship among pene-
trance, MAF, and statistical significance of an interac-
tion model is investigated in the Additional file 1, with
these results also summarized in the “Experimental
Results” section.
Step 3: assess the power to detect SNPs with only main
effects
Most of the interaction-detection methods are designed
to find either interactions or main effects (e.g.M D R ,
FIM, BEAM, MECPM and SH). Thus, it is meaningful
to see how these methods fare in detecting main effects
and also whether they detect false positive interactions
(which may involve either null and/or main effect SNPs)
when there are only main effects present.
In Step 3, we simulated 100 replication data sets, fol-
lowing a similar approach
as in Step 2. Each data set includes five main-effect
ground truth SNPs and 995 null SNPs. The penetrances
and MAFs for the five ground truth SNPs are:
SNP 1. Dominant model for the major allele, low
penetrance, MAF = 0.25.
S1 GA
11 GA
12 GA
22
0.666 0.666 0
SNP 2. Additive model for the minor allele, MAF =
0.3.
S2 GA
11 GA
12 GA
22
0 0.188 0.252
SNP 3. Additive model for the minor allele, MAF =
0.4.
S3 GA
11 GA
12 GA
22
0 0.068 0.084
SNP 4. Recessive model for the minor allele, high
penetrance, MAF = 0.25.
S4 GA
11 GA
12 GA
22
0 0 0.4128
SNP 5. Dominant model for the minor allele, low
penetrance, MAF = 0.3.
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11 GA
12 GA
22
0 0.043 0.043
Although SNP 1 and SNP 5 have relatively weaker
effects, we still included them because (1) they also
affect many subjects’ disease status, since a large propor-
tion of subjects carry the disease genotype of SNP1 and
SNP 5 (which simulates common-disease markers); (2)
our experimental results will show that these weak-effect
SNPs differentiate the performance of the methods.
Note that we configured the methods to detect both
main effects and interaction effects since, in practice, it
will not be known whether interactions are present or
not.
Design of Performance Measures
The performance of the methods is evaluated by the
accuracy of P-value assessment, various definitions of
power, reproducibility, and computational complexity.
A. Family-wise type I error rate (the accuracy of P-value
assessment)
There are 1,000 SNPs in each data set. Thus there are
multiple comparison effects, and the P-values obtained
by the methods are accordingly adjusted by Bonferroni
correction. In this way, the accuracy of P-value assess-
ment is represented by the family-wise type I error
rate: an error event occurs on a data set with no
ground truth SNPs if there are any (necessarily false)
positive detections. Since SH, MDR and FIM use Bon-
ferroni correction, we measure the accuracy of their P-
v a l u ea s s e s s m e n t sb yh o ww e l lt h es i g n i f i c a n c et h r e s h -
old (P-value) agrees with the family-wise type I error
rate.
B. Various power definitions and the ROC curve
Power can be defined in several ways, depending on
what we desire to measure. We next give several power
definitions experimentally evaluated in the sequel.
Power to progressively detect interactions (Power defi-
nition 1) the frequency with which a model’sg r o u n d -
truth SNPs are ranked within the top K positions.S e v -
eral comments are in order here. First, it is important to
note that the significance threshold is not being applied
to define power because (1) the methods’ P-value assess-
ments are, as noted earlier, conservative (as shown in
the sequel), and (2) not all methods provides signifi-
cance assessments (e.g. IG and MECPM). Second, in our
experiments, the ranking of a SNP is decided by the
strength of effect of the most significant interaction that
includes this SNP. Third, note that each data set con-
tains multiple interaction models, with the detection
power measured separately for each model. In measur-
ing the power to detect SNPs in a given interaction
amongst the top K SNPs, we are only interested in
whether the ground-truth SNPs in the interaction are
ranked higher than null SNPs, not whether they are
ranked higher than ground-truth SNPs from other inter-
actions that are present. Accordingly, when measuring
the power to detect SNPs in a given interaction, we do
not rank ground-truth SNPs from other interactions,
but only rank SNPs from the given interaction and all
null SNPs. For an M-way interaction, let {xK(i), i =
1,2,...,100} be the number of its ground-truth SNPs
reported within the top K SNPs over the 100 replicated
data sets. The power for this interaction model is then
given by:
Power(K)=
1
100 · M
100 
i=1
xK(i) (2)
We can also define power over the entire ground-
truth SNP set by setting M = 15 and considering all
ground-truth SNPs in the ranking.
Power to precisely detect interactions (power defini-
tion 2: exact interaction power) for an M-way ground-
truth interaction, how likely it is detected amongst the
top K M-way candidates produced by a method.T h i s
power definition evaluates the sensitivity to detect the
interaction as a whole, rather than as individual SNPs.
Again, similar to power definition 1,i ne v a l u a t i n gt h e
top KM -way candidates, we only consider M-way com-
binations that include ground-truth SNPs from the
interaction of interest and null SNPs, i.e.w ee x c l u d eM-
way SNP combinations involving any SNPs that partici-
pate in other ground truth interactions. Mathematically,
for an M-way interaction {s1,..., sM}, in the ith data set, if
{s1,..., sM} is detected within the top KM -way candi-
dates, x2, i(K)=1 ;o t h e r w i s e ,x2, i(K)=0 .P o w e rdefini-
tion 2 is then given by:
Power(K)=
1
100
100 
i=1
x2,i(K)
P o w e rt od e t e c ta tl e a s t1S N Pi nt h eg r o u n d - t r u t h
interaction (power definition 3: partial interaction
power) As revealed by the definitions of the interac-
tion models, a subset of the interacting SNPs may
have strong association to disease risk. Detecting an
interaction subset should be acceptable since this
gives a good “clue” to help further identify the com-
plete interaction. We thus give power definition 3 as
follows: for an M-way interaction model {s1,...,sM}, if
any SNP from {s1,...,sM}i sw i t h i nt h et o pK SNPs
reported by the methods (excluding other ground-
truth SNPs that do not participate in this interaction
model), x3,i(K)=1 ;o t h e r w i s e ,x3,i(K)=0 .P o w e rdefi-
nition 3 is then given by:
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1
100
100 
i=1
x3,i(K).
Power to detect individual SNPs (power definition 4:
single SNP power) The power definitions above ignore
differences between SNPs within the same interaction, e.
g., differences in MAF, asymmetric penetrance table and
thus different main effects, which may largely affect
their potential for being detected. So it is also necessary
to see how well individual ground-truth SNPs with dif-
ferent MAFs, penetrances, and main effects, are detected
by the 5 methods. Accordingly, we give power definition
4 as follows. For a ground-truth SNP sj,j= 1,2,...,15, if sj
is within the top K SNPs reported (excluding the other
ground-truth SNPs), xi(K) = 1; otherwise, xi(K) = 0. The
single SNP power for sj is then given by:
Power(K)=
1
100
100 
i=1
xi(K).
ROC curve We also evaluate the methods via the ROC
curve, which shows how many ground-truth SNPs are
detected for a given false positive SNP count.
C. Reproducibility
The estimated power, even if high, could deviate signifi-
cantly across different data set replications, due to the
inherent randomness in our simulation approach. Thus,
we also want to see how reproducible the detection
power is over the data set replications. To evaluate this,
we measure the standard deviation of the estimated
power across the replicated data sets.
Reproducibility(K)
=
  
 1
100
100 
i=1

xi(K) −
1
100
100 
i 
xi (K)
	2
D. Computational complexity
Computational complexity was measured by the execu-
tion time and memory occupancy of the methods for
the same platform.
Experimental Results
In Step 1, we evaluated the three methods with asymp-
totic statistics (FIM, BEAM and SH). In Step 2, we eval-
uated all eight methods (as described in the “Method”
section) on the 1000-SNP data sets, and six methods
( F I M ,I G ,B E A M ,M E C P M ,S Ha n dL R )o nt h e1 0 , 0 0 0 -
SNP data sets - we do not evaluate MDR for the
10,000-SNP data sets because the high memory occu-
pancy of the MDR software prevents this evaluation. We
also evaluated six methods (MDR, FIM, BEAM,
MECPM, SH and LR) in Step 3 - we do not evaluate IG
and LRIT, because, by design, they only output multi-
locus interaction candidates, and thus are inappropriate
to be assessed in Step 3’s main effect evaluation. Specifi-
cally, IG and LRIT will necessarily have 0 true positives,
no matter how well they detect interactions involving
the main-effect-only SNPs, since in Step 3 only “singlet”
main effects are considered to be true positives. MDR,
BEAM, SH and MECPM were all implemented using
the authors’ freely available software. LR, LRIT, FIM and
IG were implemented using C++, with the software
freely available. The eight methods were tested on the
same platform: OS: Windows, CPU: 3G, RAM: 2G. The
parameters used by the respective methods follow their
default settings wherever possible. We only modified
one parameter when testing MDR: we used its heuristic
search (1 hour execution time limit) instead of exhaus-
tive search when testing MDR on the 1000-SNP data
sets in step 2, because exhaustive search of MDR
required huge memory and quite impractically high
computational cost - when implementing MDR with
exhaustive search, our machine crashed from running
out memory; moreover, the estimated exhaustive-search
MDR execution time for a 1000-SNP, 2000-sample data
set is 1.4 × 10
6 seconds (roughly 15 years) on our plat-
form. Here we compare the eight peer methods along
several performance fronts. The results are then further
evaluated and summarized in the “Discussion” section.
Accuracy of P-value assessment in step 1
Based on the definition in the subsection “Design of
Performance Measures”, we tested the accuracy of P-
value assessment for BEAM, SH, and FIM on the 1,000
data sets in step 1. Regarding the other methods, IG
and MECPM do not give significance assessments, while
the significance assessment of MDR is (necessarily)
accurate since it uses random permutation testing
(However, it should also be noted that MDR only evalu-
ates the significance of the top-ranking interaction.
Thus, in practice, MDR does not in fact use a P-value
to practically set an interaction detection threshold.).
T h ea v e r a g ef a m i l y - w i s et y p eIe r r o rr a t e sa td i f f e r e n t
significance thresholds were calculated. Since each inter-
action order has a different Bonferroni penalty, we sepa-
rately list the results for 1st, 2nd, and 3rd orders, shown
in Table 1. BEAM, SH and FIM all have accurate
family-wise type I error rates at 1st order, but give con-
servative results (empirical family-wise type I error rate
is less than expected) at 2nd and 3rd order. BEAM is
the most conservative and FIM the least. Thus, the P-
values generated by these methods are conservative, and
not to the same degree. Thus the estimation of power
(at the targeted type I error rate value) is likewise both
conservative and not truly comparable across the
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tiveness, which we subsequently discuss.
Power (definition 1) and ROC curve in step 2
We measured power (definition 1) for each interaction
model and also for the entire 15-SNP ground-truth set.
F i g u r e4a n d5s h o ws o m eo fo u rr e s u l t sf o r1 0 0 0S N P s
and 10,000 SNPs in each data set, respectively. Many
more results, under different parameter configurations,
are given in the Additional file 1.
For the 1000-SNP case (Figure 4), although the meth-
ods can detect some SNPs with strong interacting
effects (Figure 4(c), model 2), most of the methods
(MDR, BEAM, IG, FIM, SH, and LR) miss many other
ground-truth interacting SNPs at a low false positive
SNP count (i.e., for small K) (Figure 4(b), (d), (e) and 4
(f)); further increases in power are modest and are only
attained by accepting many more false positive SNPs.
Comparatively, MECPM performs quite well on most
interaction models (including the difficult five-way (Fig-
ure 4(f)) and the three-way interactions (Figure 4(d) and
4(e)), except for model 1 (Figure 4(b)). Only a partial
curve is shown for MECPM because MECPM uses the
BIC criterion to choose its model order (and, thus, the
number of interactions) [40]. Few true SNPs are added
as K is increased beyond the BIC stopping point –
MECPM has high specificity at the BIC stopping point
[40] (MECPM specificity = 0.99 for the whole ground
truth SNP set at the BIC stopping point). Accordingly,
MECPM execution was terminated shortly after the BIC
stopping point. From Figure 4(a), MECPM is overall the
best-performing method, with SH second, BEAM third,
FIM fourth, the baseline LR fifth, LRIT sixth, IG seventh
and MDR eighth. Individual methods perform more
favorably for certain models, e.g. IG performs well for a
3-way model (Figure 4(e)). Also, all methods tend to
detect more interacting SNPs with strong main effects
than those with weak main effects (power of all the
methods on models 2 and 3 is generally higher than on
models 1, 4, and 5). We give some explanation for these
results in the “Discussion” section.
For the 10,000-SNP case (Figure 5), we have similar
o b s e r v a t i o n sa si nt h e1 0 0 0 - S N Pc a s e ,e x c e p tt h a tt h e
general performance of all methods is degraded. It is
worth noting that all the methods perform comparably
to their 1000-SNP detection power for model 2 (Figure
5(c)), and MECPM also performs comparably to its
1000-SNP detection power for models 3 and 4 (Figure 5
(d) and 5(e)). MECPM is the overall best-performing
method, with SH second, BEAM third, LR fourth, LRIT
fifth, FIM sixth and IG seventh.
Impact of penetrance, MAF, and LD on power (definition 1)
Figure 6 shows the power for different penetrance,
MAF, and LD factors. The power is calculated based on
the whole ground-truth SNP set. More detailed results
Table 1 The average family-wise type I error rates (step
1) for BEAM, SH and FIM under the significance
threshold of 0.1 (after Bonferroni correction). More
results can be found in the Additional file 1
family-wise type I error rate BEAM SH FIM
1st order 0.094 0.084 0.097
2nd order 0 0.026 0.032
3rd order 0 0.002 0.006
0 20 40 60 80 100
0
0.2
0.4
0.6
0.8
1
D
e
t
e
c
t
i
o
n
 
p
o
w
e
r
Number of top-ranked SNPs selected
0 20 40 60 80 100
0
0.2
0.4
0.6
0.8
1
D
e
t
e
c
t
i
o
n
 
p
o
w
e
r
Number of top-ranked SNPs selected
0 20 40 60 80 100
0
0.2
0.4
0.6
0.8
1
D
e
t
e
c
t
i
o
n
 
p
o
w
e
r
Number of top-ranked SNPs selected
(a)                                      (b)                                        (c)   
0 20 40 60 80 100
0
0.2
0.4
0.6
0.8
1
D
e
t
e
c
t
i
o
n
 
p
o
w
e
r
Number of top-ranked SNPs selected
0 20 40 60 80 100
0
0.2
0.4
0.6
0.8
1
D
e
t
e
c
t
i
o
n
 
p
o
w
e
r
Number of top-ranked SNPs selected
0 20 40 60 80 100
0
0.2
0.4
0.6
0.8
1
D
e
t
e
c
t
i
o
n
 
p
o
w
e
r
Number of top-ranked SNPs selected
 (d)                                     (e)                                         (f) 
Figure 4 Power evaluation (definition 1) of the eight methods on 100 replication data sets with parameter setting: θ =1 . 4 ,b =1 ,l =
null. (a) evaluates the power on the whole ground-truth SNP set, and (b) (c) (d) (e) (f) evaluate the power individually on the 5 interaction
models. Blue curve - SH, magenta curve - FIM, green curve - MDR, black curve - IG, cyan curve - MECPM, grey curve - LRIT, yellow curve - LR.
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Page 12 of 23are given in the Additional file 1. From Figure 6, a smal-
ler penetrance value or MAF significantly degrades the
power curves of the methods. Among the methods, SH
is most robust to changes in penetrance and MAF, and
IG is most sensitive to these changes.
Reproducibility of power (definition 1)
We measured the reproducibility by the standard devia-
tion of power across the 100 replication data sets. These
results are given in the Additional file 1.
Power (definition 1) to detect interacting SNPs for a fixed
significance threshold
Although the statistical significance level is unreliable
for measuring performance of the methods (as illu-
strated in Table 1), we want to give readers an empirical
s e n s eo fh o wt h em e t h o d sp e r f o r mw h e nu s i n gt h es t a -
tistical significance level to select candidate SNPs in the
step 2 experiment. These results, given in the Additional
file 1, show that using the same significance threshold,
the methods detect very different numbers of both true
positive and false positive SNPs. Moreover, considering
the balance of true positives and false positives achieved
by each of the methods, none of them performs
strongly.
Power to detect entire interactions (definition 2)
Based on power definition 2,w ed i de x p e r i m e n t st o
evaluate all the methods on the 1000-SNP data sets of
Step 2. Considering the high computational complexity
and the applicability of the methods, we compare the
power of IG, LRIT, FIM, SH and MDR on 2-way inter-
actions, the power of FIM, SH, and MDR on 3-way
interactions, and the power of MDR on 5-way interac-
tions. Figure 7 shows the results. Due to the limited
number of total interactions output by BEAM and
MECPM, we do not evaluate BEAM here, and list the
power of MECPM only at its stopping point: model 1 -
0, model 2 - 0.96, model 3 - 0.94, model 4 - 0, model 5
- 0.46.
We can observe that all the methods have poor per-
formance for models 1 and 4. For models 3 and 5, all
the methods fare poorly except for MECPM. For model
2, IG, LRIT and FIM have very good performance
(power = 1); MECPM also performs well (power =
0.96); while the other methods still perform poorly.
Power to detect at least 1 SNPin an interaction - partial
interaction detection (definition 3)
Based on power definition 3,w ee v a l u a t e dS H ,B E A M ,
I G ,F I M ,M D R ,L R I Ta n dM E C P M .T h em a j o rr e s u l t s
a r es h o w ni nF i g u r e8 .D u et ot h el i m i t e dn u m b e ro f
total interactions output by MECPM at its stopping cri-
teria, we give a text description, instead of drawing a
curve, to show the power at its stopping point: model 1
- 0.17, model 2 - 1, model 3 - 0.98, model 4 - 0.97,
model 5 - 0.46. From Figure 8, BEAM, SH, FIM, LRIT
and MECPM obtain good results for models 2, 3, 4, 5.
We believe that these good results are partly due to the
relatively strong main effects of SNPs involved in these
interaction models. Note that there is a substantial
increase in power compared to Figure 7. Also, by com-
paring with the results for power definition 1 (Figure 4),
we can see that there is largely increased power for
(a)                                        (b)                                         (c)   
                     (d)                                        (e)                                          (f) 
Figure 5 Power evaluation (definition 1) of six methods on 10 replication data sets with parameter setting: θ =1 . 4 ,b =1 ,l = null.( a )
evaluates the power on the whole ground-truth SNP set, and (b) (c) (d) (e) (f) evaluate the power individually on the 5 interaction models. In
(c), all the methods have overlapped power curve at the upmost part of the figure. Magenta curve - FIM, black curve - IG, red curve - BEAM,
blue curve - SH, cyan curve - MECPM, grey curve - LRIT, yellow curve - LR.
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partly detected by the methods.
Power to detect individual SNP main effects (definition 4)
Based on Figure 9, we can confirm our previous state-
ment that main effects play an important role in deter-
mining whether or not a SNP can be detected. For
example, the two SNPs in model 2 (odds ratio: 1.89 in
the basic model) and SNP A (odds ratio: 2.45 in the
basic model) in model 4 have strong main effects, and
all the methods detect them well.
Also, we observe similar power for SNPs participating
in interactions with symmetric penetrance tables and
the same MAFs. For example, all the SNPs in model 1
and model 5 have similar power; likewise for SNPs B
and C in models 3 and 4. This observation is reasonable
since these SNPs not only have the same main effects,
but also have the same interaction effects.
For SNPs participating in interactions with a sym-
metric penetrance table but different MAFs, an interest-
ing (and perhaps unexpected) finding is that for model
2, the power to detect SNP A (MAF = 0.2), is greater
than the power to detect SNP B, which has a larger
MAF (MAF = 0.3). We give theoretical justification for
this result in section 1 of the Additional file 1.
Performance for step 3, the main-effect-only case
We used power definition 4 to evaluate performance of
the methods on the main-effect-only data sets in Step 3.
W ed i dn o ti n c l u d et h eI Ga n dL R I Tm e t h o di nt h i s
Step because IG and LRIT only detect multilocus inter-
actions, not single (main effect) SNPs; thus, for Step 3,
(a) ș=1.4, ȕ=1, l=null                    (b) ș=1.3, ȕ=1, l=null                  (c) ș=1, ȕ=1, l=null
(d) ș=1.4, ȕ=0.7, l=null              (e) ș=1.3, ȕ=0.7, l=null                (f) ș=1, ȕ=0.7, l=null    
(g) ș=1.4, ȕ=1, l=0.8                    (h) ș=1.3, ȕ=1, l=0.8                       (i) ș=1, ȕ=1, l=0.8    
(j) ș=1.4, ȕ=0.7, l=0.8               (k) ș=1.3, ȕ=0.7, l=0.8                  (l) ș=1, ȕ=0.7, l=0.8   
Figure 6 The impact of penetrance value (θ), MAF (b), and LD factor (l) on power for the whole ground-truth SNP set. Blue curve - SH,
magenta curve - FIM, green curve - MDR, black curve - IG, cyan curve - MECPM, yellow curve LR..
Chen et al. BMC Genomics 2011, 12:344
http://www.biomedcentral.com/1471-2164/12/344
Page 14 of 23                     (a) Model 1                                   (b) Model 2                                   (c) Model 3      
                    (d) Model 4                           (e) Model 5
Figure 7 Power evaluation (definition 2) of the methods on 100 replication data sets with parameter setting: θ = 1.4, b =1 ,l = null.I n
(a), FIM, IG, MDR and LRIT have power constantly equal to 0; in (b) FIM and IG and LRIT have power constantly equal to 1; in (d) SH, FIM and
MDR have power constantly equal to 0. Blue curve - SH, magenta curve - FIM, green curve - MDR, black curve - IG, grey curve - LRIT, yellow
curve - LR.
                 (a) Model 1                                     (b) Model 2                                 (c) Model 3       
                  (d) Model 4                                   (e) Model 5
Figure 8 Power evaluation (definition 3) of the eight methods on 100 replication data sets with parameter setting: θ =1 . 4 ,b =1 ,l =
null. Blue curve - SH, magenta curve - FIM, green curve - MDR, black curve - IG, grey curve - LRIT, yellow curve - LR.
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Page 15 of 23involving only main effects, detected interactions, even
ones involving the main effect SNPs, are necessarily
false positive interactions. Figure 10 shows the power
curves, from which we observe that, except for MDR,
most methods (FIM, BEAM, SH, MECPM, LR) achieve
similar, good power at the beginning, with SH becoming
a bit better as K increases.
We also evaluated whether the methods detect false
positive interactions when there are only main effects.
Here we evaluated the 3 methods that give P-value
(a) Model 1, SNP A                       (b) Model 1, SNP B                      (c) Model 2, SNP A 
(d) Model 2, SNP B                       (e) Model 3, SNP A                    (f) Model 3, SNP B
(g) Model 3, SNP C                      (h) Model 4, SNP A                      (i) Model 4, SNP B 
(j) Model 4, SNP C                       (k) Model 5, SNP A                 (l) Model 5, SNP B
(m) Model 5, SNP C                     (n) Model 5, SNP D                  (o) Model 5, SNP E  
Figure 9 The power to detect individual SNPs, for parameter θ = 1.4, b =1 ,l = null. Blue curve - SH, magenta curve - FIM, green curve -
MDR, black curve - IG, cyan curve -MECPM, grey curve - LRIT, yellow curve - LR.
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Page 16 of 23assessments, looking at the number of false positive
interactions detected under the P-value of 0.1 after Bon-
ferroni correction. Table 2 lists the results, from which
we can see that BEAM and SH are quite good at inhibit-
ing false positive interactions caused by marginal effects,
but FIM produces many false positive interactions.
Computational complexity and memory occupancy
Computational complexity for the eight methods was
evaluated for the same platform: OS: Windows, CPU:
3 G ,R A M :2 G .S H ,I G ,F I M ,L R ,L R I T ,M E C P Ma n d
BEAM do not require much memory, but the exhaustive
search used by MDR requires an impractical amount of
memory for a large number of SNPs. Thus, as noted
earlier, we applied the heuristic search option in the
MDR software, with a 1 hour time limit to avoid mem-
ory overflow. Figure 11(a) shows that, as expected, most
methods’ execution times increase linearly with sample
size. The exception is BEAM execution, which grows
more quickly. Figure 11(b) shows execution times for
different numbers of SNPs. SH obtains the highest effi-
ciency (~ linearly increasing execution time); IG and
BEAM are more time consuming (~ quadratically
increasing); and FIM is most time-consuming (~ cubic
in the number of SNPs). Besides Figure 11(b), we also
list execution time of LR, LRIT and MECPM (at
MECPM’s stopping point): the execution time of LR on
1000-SNP data and 10000-SNP data is 1 second and 10
seconds, respectively; the execution time of LRIT on
1000-SNP data and 10000-SNP data sets is 24 seconds
and 576 seconds, respectively; the execution time for
MECPM on the 1000-SNP data and 10,000 SNP data
was 7033 seconds and 25944 seconds, respectively.
Compared with Figure 11(b), we can see that MECPM’s
computation complexity is, relatively, quite high for
1000 SNPs, but is in fact lower than that of several of
the other methods for 10,000 SNPs.
Discussion
General Summary of the Study and Its Results
We report a comparison of eight representative meth-
ods, multifactor dimensionality reduction (MDR), full
interaction model (FIM), information gain (IG), Bayesian
epistasis association mapping (BEAM), SNP harvester
(SH), maximum entropy conditional probability model-
ing (MECPM), logistic regression with an interaction
term (LRIM), and logistic regression (LR). The first
seven were specifically designed to detect interactions
among SNPs, and the last is a popular main-effect test-
ing method serving as a baseline for performance eva-
luation. The selected methods were compared on a
large number of simulated data sets, each, consistent
with complex disease models, embedded with multiple
sets of interacting SNPs, under different interaction
models. The assessment criteria included several rele-
vant detection power measures, family-wise type I error
rate, and computational complexity. The principal
experimental results are as follows: i) while some SNPs
in interactions with strong effects are successfully
detected, most of the methods miss many interacting
SNPs at an acceptable rate of false positives; in this
study, the best-performing method was MECPM; ii) the
statistical significance assessment criteria, used by some
of these methods to control the type I error rate, are
quite conservative, which further limits their power and
makes it difficult to fairly compare them; iii) the power
varies for different models as a function of penetrance,
minor allele frequency, linkage disequilibrium and mar-
ginal effects; iv) analytical relationships between power
and these factors are derived, which support and help
explain the experimental results; v) for these methods
the magnitude of the main effects plays an important
role in whether an interacting SNP is detected; vi) most
methods can detect some ground-truth SNPs, but fare
modestly at detecting the whole set of interacting SNPs.
Based on the simulation data sets used in this study,
which include multiple interaction models present in each
data set in Step 2, most of the methods miss some
interacting SNPs, leading to only moderate power at low
false positive SNP counts (Figures 4, 5)
Compared to the promising powers achieved for the
simulation studies reported in the methods’ respective
papers, the degraded performance seen in this compara-
tive study for most methods is attributed to the more
difficult yet likely more realistic simulation data that we
Figure 10 Power evaluation of 6 methods (using power
definition 1) on main-effects-only data (step 3). Blue curve - SH,
magenta curve - FIM, green curve - MDR, cyan curve - MECPM,
yellow curve - LR.
Table 2 The average number of false positive
interactions (step 3) for BEAM, SH and FIM under the
significance threshold of 0
number of false positives BEAM SH FIM
2nd order 0 0 2.21
3rd order 0 0 64.19
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Page 17 of 23used. The methods (excepting LR and MECPM) were
previously reported as powerful on simulation data sets
including only a single, strong ground-truth interaction,
but our study included 5 interactions present in each
data set to simulate multiple genetic causes for complex
diseases. The disease risk is thus effectively divided
among the 5 interaction models, giving each a weaker
(less easily detected) effect.
Main effects play an important role in whether a ground-
truth SNP is detected at low false positive SNP counts
Another notable finding is that the main effects of the
interacting SNPs affect their likelihood of being detected
at low false positive SNP counts by most methods. For
interaction models with very weak marginal effects
(models 1 and 5), all the methods have low power (see
Figure 4(b) and 4(f)). Although some methods (e.g. SH)
emphasize the detection of interactions with weak mar-
ginal effects, their results on these models are very mod-
est. Heuristic search strategies used by the methods
count on at least one SNP in the interaction having a
relatively strong effect; this explains why model 1, with-
out strong main effects, is difficult to detect. Moreover,
the huge search space for 5-way interactions makes it
easy for heuristic search strategies to miss model 5.
For the same interaction model, different levels of power
are achieved by the eight methods
For each interaction model, the power varies across
methods because of the quite different detection princi-
ples applied by the methods. For example, IG and LRIT,
which are based on pairwise SNP statistics, can detect
2-way interaction effects well (see models 2 and 4,
where model 4 can be considered as two overlapped 2-
way interactions), but IG and LRIT gets poorer results
for higher-order models. For the difficult 5-way interac-
tion, only MECPM gave promising results.
Power on the whole ground-truth SNP set - MECPM
performs the best, while MDR performs the worst
From Figure 4(a), MECPM achieves the best perfor-
mance; BEAM, SH, FIM, LR, LRIT and IG have similar
and moderate performance; MDR performs the worst,
among the eight methods we tested. From Figure 6, SH
outperforms BEAM and FIM for weaker effects (i.e., for
discounted penetrance values and MAF). Here we briefly
discuss how these performance differences are a product
of the different methodologies employed.
Power may be degraded by an insufficiently sensitive
ranking criterion, by the heuristic search strategy used,
or by a suboptimal output design of a method. The
high computational complexity of MDR necessitates
using its heuristic search option to keep the running
time/memory usage in a reasonable range. This heuris-
tic search forces a significantly reduced search space,
and hence the performance of MDR is expected to be
degraded.
The ranking criterion of IG detects pure interaction
effects (see equation (4) and the definition of mutual
information). However, what really affects disease risk is
a combination of both pure interaction effects and main
effects. Additionally, IG is only explicitly designed to
detect 2-way interactions, and thus may have difficulty
detecting higher order ones.
Comparatively, MECPM, BEAM, FIM and SH have
less critical limitations, with these mainly in the sensitiv-
ity of their ranking criteria and their use of heuristic
search – e.g., the difficulty for heuristic search to pick
up interactions with weak marginal effects and high-
order interactions due to the large search space
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Figure 11 Execution time (sec) of 4 methods for: (a) number of SNPs = 1,000; (b) number of subjects = 2,000. Due to limited space in
(b), we list hereby the execution time of the methods on 2000-subject 10,000-SNP data: SH - 962 seconds, IG - 18291 seconds, BEAM - 36423
seconds, FIM - 91251 seconds.
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Page 18 of 23(Consider a contingency table with 3
5 = 243 cells for a
5-way interaction.).
The performance of the methods is sensitive to changes
in penetrance value, MAF, and LD
From Figure 6, the seven methods all have clearly
decreased power when we reduce penetrance values and
the MAF, or replace ground-truth SNPs by surrogates
in LD with them. Among the methods, SH is the most
robust while IG is the most sensitive to these factors.
Besides our empirical results, a theoretical analysis of
how power changes with penetrance or MAF is given in
the Additional file 1. The analytical results, which are
consistent with (and thus support and explain) our
experimental results are as follows: 1) increasing the
penetrance of an interaction model results in both a
stronger (more easily detected) joint interaction effect
and in stronger marginal effects of the participating
SNPs; 2) increasing the frequency of a disease-related
genotype results in a stronger joint effect, under certain
conditions; 3) the impact of genotype frequency on
main effects is more complicated – when the marginal
frequency, a, of a disease-related genotype is small, the
strengths of the marginal effects increase when a
increases, and when a is large, the strengths of the mar-
ginal effects decrease as a increases.
Most methods can partially but not exactly detect the
interactions
The results for power definition 2 (see Figure 7) are
quite different from those for power definition 1 (see
Figure 4), indicating that most methods detect the inter-
acting ground truth SNPs as singlets or subsets of the
ground truth interactions. There are multiple reasons
for this, in some cases method-specific. For example,
the large degrees of freedom of FIM render a high false
positive rate, making ground-truth interactions easily
buried amongst many false positives; due to the use of
heuristic search strategies, the methods may not even
evaluate the ground-truth interactions as candidates;
also, for some methods, e.g. FIM, successful detection of
an interaction relies on first detecting main effects for
(at least some) SNPs involved in the interaction, thus
this type of heuristic search strategy will miss ground-
truth interactions that possess only weak main effects;
moreover, SH excludes SNPs with strong main effects
from higher-order search, so SH in particular will miss
interactions that possess strong main effects (see Figure
7(b)).
The P-value assessments of BEAM, SH and FIM are
variable across method and all are overly conservative
From the subsection “Power for a fixed significance
threshold“ and results given in the Additional file 1, we
observe that for the same significance threshold, BEAM,
SH and FIM have quite different power and false posi-
tive SNP counts. Also, in the subsection “Accuracy of P-
value assessment in step 1“, we showed that their P-
value assessments are conservative for 2nd and 3rd
order interactions. From further experiments, we con-
clude that this phenomenon originates from three fac-
tors: the heuristic search strategies, dependencies
between SNP combinations, and the summary statistics
used by the methods.
For BEAM, SH, and FIM, the heuristic search strate-
gies evaluate fewer SNP combination candidates than
the number actually penalized in the Bonferroni correc-
tion. Moreover, SH and BEAM exclude SNPs with
strong marginal effects from high-order interactions,
which further decreases the number of searched SNP
combinations. So the Bonferroni-corrected P-value is
smaller than it should be. Also, some SNP combinations
have dependencies with others, either because they
share a common SNP subset and/or because SNPs in
different subsets are in LD. Such dependencies make the
Bonferroni correction inherently conservative.
Besides heuristic search and dependencies, the conser-
vativeness also derives from the summary statistics
themselves. The authors of BEAM evaluated the B sta-
tistic’s conservativeness with exhaustive search. In the
Additional file 1, we likewise evaluate conservativeness
of the c
2 statistics applied by SH and FIM. We consid-
ered the case where there is neither multiple testing nor
heuristic search. The c
2 statistics turn out to be conser-
vative, becoming more so as the significance threshold
is decreased (see Tables 1, 2 in the Additional file 1).
Theoretically, such conservativeness may come from the
discreteness of the SNP data. Since the c
2 statistics in
SH and FIM are calculated from the discrete-valued
SNP data, the c
2 statistics are also discrete. At the tail
part of the c
2 distribution, two consecutive discrete c
2
values may correspond to very different significance
levels. For example, let the P-values of consecutive c
2
values be p1, p2 (p1 >>p2); when the significance thresh-
old is p0 and p1 >p0 >p2, the type I error rate actually
corresponds to p2, which is much less than p0,m a k i n g
the results quite conservative.
Limitations of the Current Study and Future Work
There are a number of possible extensions of this simu-
lation study that we intend to consider in our future
work. First, our current simulation software only han-
dles categorical traits and categorical (ternary-valued,
SNP) covariates. Environmental covariates and admix-
ture-adjusting variables could be either quantitative or
ordinal-valued. Likewise, traits (phenotype) could be
quantitative or ordinal. There are natural ways of
extending our current simulation approach to allow for
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Page 19 of 23these more general covariate and trait types, which we
will consider in future work. Second, we have not inves-
tigated missing SNP-values and their effect on detection
power. Third, while we have chosen five plausible pene-
trance function models, another possibility would be to
use “data-driven” penetrance functions, i.e.p e n e t r a n c e
functions estimated based on real GWAS data sets with
known ground-truth and known (i.e., previously
detected) interactions.
Conclusions
The methods explored in this study are useful tools in
the exploration of potential interacting loci. Each of the
methods studied here has its strengths and weaknesses.
Our comparative examination of these methods suggests
that continued research into methods that test for inter-
acting loci is necessary to expand the tools available to
researchers and to achieve improved power for detecting
complex interactions, along with accurate assessment of
statistical significance.
Methods
Methods Tested in the Comparison Study
The eight [32-35,39-41] methods originate from differ-
ent underlying techniques and principles, and thus can
be categorized in different ways, as shown in Table 3.
FIM, BEAM, SH, LRIT, and LR asymptotically approxi-
mate the null distribution to assess statistical signifi-
cance; MECPM models SNP interactions under a
maximum-entropy principle, and uses the Bayesian
information criterion (BIC) as the model selection strat-
egy; MDR and IG only provide a ranking of candidate
interactions. These methods employ three main search
strategies: exhaustive search (IG, LRIT and LR), stochas-
tic search (BEAM and MDR), and deterministic heuris-
tic search (SH, FIM and MECPM). Each method uses a
different detection principle: SH applies c
2 or B statistics
[32,39]; BEAM uses Bayesian inference or B statistics;
FIM, LRIT and LR are based on the logistic regression
model; IG ranks SNPs by mutual information; MDR
s e l e c t sS N P sv i ap r e d i c t i o ne r r o r ;M E C P Mu s e sB I Ct o
rank interactions and to assess statistical significance.
A brief summary of these eight methods follows.
(1) Multifactor dimensionality reduction (MDR) [33]
For a set of SNPs, MDR labels a genotype as “high-risk”
if the ratio between the number of cases and the num-
ber of controls exceeds some threshold (e.g., 1.0). A bin-
ary variable is thus formed, pooling high-risk genotypes
into one group and low-risk ones into another. If the
subject has a high-risk genotype it is predicted as a case;
otherwise as a control. The prediction error of each
model is estimated by 10-fold cross validation and
serves as the measure of association between the set of
SNPs and the disease.
(2) Full Interaction Model (FIM) [41]
In FIM, 3
d-1 binary variables xj,j= 1,2,..., 3
d-1 are intro-
duced for a subset of d SNPs and a logistic regression
model with 3
d parameters is estimated from the data. xj
(i) corresponds to the jth genotype combination (or
interaction term) of the SNP subset on the ith subject.
xj(i)=1i ft h ejth genotype combination is present for
the ith subject, and 0 otherwise. For the row vector
x(i)=[ x1(i),x2(i),...,x3d−1(i)],l e tπ(x(i)) be the disease
risk. The logistic regression is parameterized as
log


π(x(i))
1 − π(x(i))

= β0 + βx(i)T (3)
where β0, β =

β1,...,β3d−1


are estimated via maxi-
mum likelihood estimation. A likelihood-ratio test is
applied to calculate the significance of this SNP subset
via an asymptotic c
2 distribution.
(3) Information Gain (IG) [34]
Let C denote the disease status random variable. The
information gain of {A, B} is defined as
IG(A,B,C)=I(A;B|C) − I(A;B) (4)
where the mutual information I(A;B) is a non-negative
measure of the reduction in uncertainty about the value
Table 3 Properties of methods tested in this paper
Name Detection Principle Heuristic search Asymptotic null distribution Free-accessible software
MDR Prediction accuracy Stochastic No http://www.multifactordimensionalityreduction.org/
FIM Logistic regression Deterministic Yes N/A
IG Mutual Info. N/A No N/A
BEAM Bayesian model Stochastic Yes http://www.fas.harvard.edu/~junliu/BEAM/
MECPM BIC Deterministic No http://www.cbil.ece.vt.edu/software/MECPM.zip
SH c
2or B statistic Deterministic Yes http://bioinformatics.ust.hk/SNPHarvester.html
LRIT Logistic regression N/A Yes N/A
LR Logistic regression N/A Yes N/A
For the methods without free-accessible software by the authors, we provide our self-written software, as well as C++ code, at http://code.google.com/p/
simulation-tool-bmc-ms9169818735220977/downloads/list
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random variable B [61] Equivalently, it is a measure of
the statistical dependence between A and B. The condi-
tional mutual information I(A;B| C )l i k e w i s eg i v e sa
measure of the statistical dependence between A and B
given that the phenotype random variable, C, is known.
The magnitude of IG thus indicates the increased statis-
tical dependence between A and B given knowledge of
C, i.e. the strength of an interaction between loci A and
B.
(4) Bayesian Epistasis Association Mapping (BEAM) [32]
Suppose N samples (Nd cases and Nu controls) are gen-
otyped at L SNPs. BEAM partitions the L SNPs into 3
groups: markers with no association with disease, mar-
kers with only main effects, and markers with interac-
tion effects. Let the genotypes on cases be D =( d1,...,dL)
with dj =

dj1,...,djNd


representing genotype vector of
the jth SNP at all the cases. According to the above-
mentioned partitioning, D can be divided into three sub-
sets, D0, D1, and D2, where D0 is the subset consisting of
SNPs (SNP genotype vectors) with no association, D1 is
the subset consisting of SNPs with only main effects,
and D2 is the subset consisting of SNPs with interaction
effects. Likewise, let the genotypes on controls be U =
(u1,...,uL) with uj =

uj1,...,ujNu

representing genotypes
of the jth SNP at the controls. Let I =[ I1,I2,..., IL]b et h e
membership of SNPs within each group, e.g. Ij =0
means that the jth SNP has a main effect, Ij =1m e a n s
that the jth SNP has only main effects, Ij = 2 means that
the jth SNP has interaction effects. Let P() be the prob-
ability symbol. Following some assumptions [32], the
posterior distribution of I given D and U is inferred by:
P(I|D,U)
∝ P(D1|I) · P(D2|I) · P(D0,U|I) · P(I).
(5)
B a s e do ne q u a t i o n( 5 ) ,B E A Md r a w sI using the
Metropolis-Hastings algorithm. The output is the pos-
terior probability of main-effect markers and interac-
tions associated with the disease. A “B“ statistic is also
applied to measure statistical significance of SNPs and
interactions.
(5) SNP Harvester (SH) [39]
This method aims to detect interactions with weak mar-
ginal effects. It includes the following steps:
5a. Remove SNPs with significant main effects;
5b. For a fixed M,r u nt h e“PathSeeker” heuristic
search to identify M-way SNP interactions. First, ran-
domly select M SNPs to form a M-way set A = {x1,
x2,..., xM}. Second, swap one of the remaining SNPs with
each member of A, to see whether a statistical score s
(A) (e.g. c
2statistic, B statistic) increases. Then iteratively
repeat this second step until convergence; record s(A)i f
statistically significant. Then go back to the first step,
with the optimal A removed as a candidate for the next
run.
5c. Use L2-norm penalized logistic regression [37] as a
post processing step to further select interactions from
those identified in 5b.
Although SH removes SNPs with strong main effects,
for purpose of fair comparison, we still give it credit for
identifying these main-effect SNPs in calculating its
power.
(6) Maximum entropy conditional probability modeling
(MECPM) [40]
MECPM builds the phenotype posterior under a maxi-
mum entropy principle, encodes constraints into the
model that correspond 1-to-1 to interactions, flexibly
allows dominant or recessive coding for each locus in a
candidate interaction, searches interactions via a greedy
interaction growing search strategy that evaluates candi-
dates up to fifth order, and uses the Bayesian informa-
tion criterion (BIC) as the model selection strategy.
(7) Logistic regression (LR) [35]
LR is a generalized linear model used for binomial
regression. Let x(i) correspond to the genotype of a SNP
for the ith subject. x(i) = 0 denotes homozygous major
alleles; x(i) = 1 denotes heterozygous genotypes; and x(i)
= 2 denotes homozygous minor alleles. Let π (x(i)) be
the disease risk. The logistic regression is parameterized
as:
log


π(x(i))
1 − π(x(i))

= β0 + β1x(i) (6)
,w h e r eb0 and b1 are the regression coefficients,
learned via maximum likelihood. By a likelihood ratio
test, logistic regression evaluates statistical significance
for each SNP.
(8) Logistic regression with interaction term (LRIT) [35]
LRIT aims at detecting interaction effects based on the
logistic regression model. Let xm(i)a n dxn(i) correspond
to genotypes of the mth SNP and nth SNPs for the ith
subject, respectively. xm(i)=0o rxn(i) = 0 denotes
homozygous major alleles; xm(i)=1o rxn(i) = 1 denotes
heterozygous genotypes; and xm(i)=2o rxn(i)=2
denotes homozygous minor alleles. Let π (xm(i), xn(i)) be
the disease risk. The logistic regression is parameterized
as:
log


π(xm(i),xn(i))
1 − π(xm(i),xn(i))

= β0 + β1xm(i)+β2xn(i)+β3xm(i) · xn(i) (7)
,w h e r eb0, b1, b2, b3 are the regression coefficients,
learned via maximum likelihood. By a likelihood ratio
test, logistic regression evaluates the statistical signifi-
cance for this pair of SNPs (the statistical significance
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Page 21 of 23reflects the joint effects of the two individual terms and
the multiplicative term).
Additional material
Additional file 1: Supplementary information: comparative analysis
of methods for detecting interactive SNPs. This supplementary
information consists of 6 sections: S1. Section S1 presents our theoretical
analysis of the relationship between association strength, joint effect,
main effect, penetrance function, and MAF. This section also provides
some theoretical explanations about our experimental results. S2. Section
S2 presents comprehensive power evaluation results of the methods for
different interaction models and parameter settings, related to power
definition 1. The reproducibility of the methods is also shown by the
standard deviation of power. As an extension of the main text, we also
summarize our findings and analytical explanations for these results. S3.
Section S3 provides ROC curves of the methods based on the whole
ground-truth SNP set. These ROC curves illustrate the sensitivity and
specificity for the methods. The reproducibility of the methods is also
shown by the standard deviation of sensitivity. S4. Section S4 describes
in detail how the effect size (odds ratio) is calculated for each interaction
model. S5. Section S5 analyzes the conservativeness of c
2 statistics
applied by SH and FIM. This analysis partly explains why SH and FIM are
conservative. S6. Section S6 gives the empirical relationship between
power and the false positive SNP count under a given significance
threshold.
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